Prolactin (PRL) is one of the anterior pituitary hormones and has manifold actions in a wide range of vertebrates as reviewed by Bern and Nicoll (1968) . In mammals, PRL acts on the mammary gland to develop the organ and to produce milk proteins, and on the reproductive organs to stimulate progesterone synthesis and prostate development, while it has different functions in lower vertebrates. To understand this versatility of PRL function, it is necessary to study the hormone from the standpoint of the structure-function relationship.
But, so far, little is known of which domains in PRL are responsible for the respective biological actions of PRL. As the first step to approach the structure-function relationship of PRL, this study has aimed at producing recombinant rat PRL (RecrPRL) Construction of expression vector From the rPRL cDNA clone pPRL-2 (Gubbins et al., 1980) , kindly provided by Dr. R. A. Maurer of the University of Iowa, the insert, rPRL cDNA, was excised with EcoRI. The rPRL expression vector (rPRSV) was constructed in the blunt end of the Smal site of mammalian expression vector pSVL (Pharmacia LKB, Uppsala, Sweden). The EcoRI cDNA fragments formed a blunt end by being filled with the Klenow fragment (Takara, Kyoto, Japan). The physical map is shown in Fig. 1A . The insertion and orientation of the rPRL cDNA in the construct were confirmed by restriction enzyme digestion. The plasmid DNA was prepared by alkaline-SDS methods (Maniatis et al., 1982) .
Cell culture and transfection The transformed COS-1 monkey kidney cells (Gluzman, 1981) were were linearized by log-logit plot (Minegishi et al., 1981) and their slopes were compared by Student's t-test.
Preparations
of Mam-rPRL from enriched mammotrophs A mammotroph enrich cell suspension was prepared from the anterior pituitaries of male rats by the centrifugal elutriation technique using a JE-6B separation chamber (Beckman Instruments, Inc., Palo Alto, CA) as described previously (Shimokawa et al., 1988 The membrane was treated with 3% BSA in 150mM NaCl-50mM
Tris (Trisbuffered saline, pH 7.5) and incubated with anti-rPRL antiserum S-9, followed by reaction with 125I-protein A (Pharmacia LKB). The membrane was then washed with Tris-buffered saline twice and autoradiographed for 24h at an intensifying screen (E-32, Toshiba, Tokyo, Japan).
Receptor-binding test Receptor-binding activity of Rec-rPRL was analyzed by radioreceptor assay (RRA) with rabbit mammary gland according to the method of Sakai et al.(1986) .
Ovine PRL was radioiodinated by the lactoperoxidase method (Sakai et al., 1975 IEF analysis of Rec-rPRL Fig. 3 shows the IEF profile of Rec-rPRL.
Rec-rPRL showed a single peak at pH 4.9.
When Mam-rPRL was analyzed by IEF, the main peak appeared also at pH 4.9, indicating that Rec-rPRL has the same isoelectric point as natural rPRL.
Western blotting analysis of Rec-rPRL rPRLs were electrophoresed on 12% SDS-polyacrylamide gel, and detected by Western blotting with rPRL antiserum and 125I -labeled protein A as shown in Fig .4 .In this comparison of the molecular size, we used Mam-rPRL from culture medium of enriched mammotrophs as natural rPRL, because NIADDK rPRL I-5, which is stated to be 90-95% monomeric just after the preparation, might change to form aggregated molecules. The mobility of Rec-rPRL was similar to that of Mam-rPRL. Rec-rPRL gave a positive single band of molecular weight 23,000, which suggested that the signal peptide of 26 amino acids present in the precursor molecule had been removed before secretion.
A faint band (Mw: 17,000) was observed in lane B besides Rec-rPRL.
This band was also present in the control (lane A), but not in Mam-rPRL.
Western blotting analysis of GIT medium itself did not show any immunoreactive materials (data not shown). These faint bands are supposed to be a substance cross-reacting to protein A which was produced by COS-1 cells, because we could not RRA in the culture medium of non-transfected COS-1 cells.
Receptor-binding of Rec-rPRL NIADDK rPRL I-5 and the culture medium of the transfected COS-1 cells (RecrPRL) were tested for their ability to compete with 125I-oPRL for PRL receptor in the mammary microsomes of mid-lactating rabbits (Fig. 5) . The amount of Rec-rPRL was determined on the basis of the RIA results. The culture medium of the intact COS-1 cells did not influence the receptor binding of 125I-oPRL at any dilution tested . The inhibition curves obtained with Rec-rPRL and rPRL I-5 were parallel, and the affinity of rPRL I-5 seemed to be 1.2 times greater than that of Rec-rPRL.
Nb 2 lymphoma cell bioassay The cell growth of Nb 2 lymphoma cells cultured with various concentrations of RecrPRL or rPRL I-5 was examined as shown in. Fig.6 .
Both rPRLs stimulated the cell growth in a dose-dependent manner between 5pg and 25 ng/ 1.5 ml/well.
The dose-response curves were parallel.
The growthpromoting activity of Rec-rPRL was about 1.2 times higher than that of rPRL I-5.
Morphological study Fig. 7 shows the changes in the secretory materials in lumen of mouse mammary gland fragment incubated in the presence and absence of rPRL.
The absence of rPRL is characterized by the complete or nearly complete absence of eosinophile substance in the lumina as shown in Fig.7A .
The grade of secretory materials in these lumina was scored zero. Figures 7B and C show the tissues incubated with 50ng/ml rPRL I-5 and RecrPRL, respectively. Pictures indicated strong positive response to rPRL characterized by the presence of secretory materials in the lumina. They were scored 4. The dose response curves obtained with Rec-rPRL and rPRL I-5 are shown in Fig. 7D . The results indicated that Rec-rPRL also had a dosedependent effect on the mammary tissue secretory function. The potencies of RecrPRL and rPRL I-5 were almost the same.
Discussion
Recently, two laboratories have succeeded in producing recombinant bovine and chicken PRLs (bPRL and cPRL, respectively) in bacterial cells (Luck et al., 1989; Hanks et al., 1989) .
These PRLs have an artificial Nterminal methionyl residue in addition to a signal peptide of 26 amino acids which is naturally present in their precursors. Luck et al.(1989) reported that bPRL was extracted from the bacterial cell body by press lysis, and that the redoxin treatment was necessary to obtain full biological activity of the bacterial products.
These facts indicated that the bacterial product requires manipulation of the gene which gives a methionyl residue at the N-terminal, extraction from the bacterial cell body, and reduction-reoxidation treatment for full biological activity.
Several attempts to produce recombinant molecules in mammalian cells, including our experiment on porcine GH (Kato et al., 1990) , showed that the signal peptides in the precursor molecules were removed and secreted in the culture medium. If the hormone which is expressed in mammalian cells has full biological activity, this method has advantages over the expression molecule in bacterial cells because 1) extraction of the hormones from the culture medium would be easier than from the bacterial cell bodies, 2) removal of the N-terminal methionyl residue is not necessary, 3) reduction-reoxidation treatment is not necessary.
In the present study, we successfully obtained Rec-rPRL from transfected COS-1 cells with a mammalian expression vector by the DEAE-dextran method. Both Rec-rPRL and standard rPRL had the same molecular weight of 23,000 and had the same isoelectric point (pI 4.9). We also confirmed that RecrPRL is similar to natural rPRL from the point of biological activity, namely the receptor binding activity, Nb 2 cell growth promoting activity, and the production of secretory materials in the mammary gland. It was shown that Rec-rPRL has about the same biological activity as rPRL I-5 used as a standard preparation.
This rPRL I-5 was highly purified for radioiodination in RIA. Its biological potency is as high as 30 IU/mg. These facts indicated that Rec-rPRL had a natural bioactive form.
Successful production of biologically active PRL enables us to proceed in two directions in the research of PRL. Firstly, the mass production of recombinant PRL would be possible in mammalian cells if stable expression in mammalian cells were achieved. The serum free culture media will be helpful for the purification of the product. Secondly, the site-directed mutants could be produced in mammalian cell easily without any extra treatments.
Transient expression in serum free media, and the techniques of characterization for receptor-binding and biological activity would help us to survey numerous mutants in the study on the structure-function relationship.
